Stocktoria
SBC Medical Group Holdings Inc SBC
SBC Medical Group Holdings Inc (SBC) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $173.6M at a 29.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.447 |
| Retained earnings / assets | 0.632 |
| EBIT / assets | 0.177 |
| Equity / liabilities | 2.248 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SBC | SBC Medical Group Holdings Inc | 3/9 | 8.55 | 6.7 | -15.5% |
| LFMD | LifeMD, Inc. | 5/9 | -9.85 | 13.9 | +25.3% |
| AIRS | Airsculpt Technologies, Inc. | 3/9 | -0.63 | — | -15.8% |
| CCM | Concord Medical Services Holdings Ltd | 6/9 | -3.98 | — | +25.2% |
| TOI | Oncology Institute, Inc. | 4/9 | -5.27 | — | +27.8% |
| HIMS | Hims & Hers Health, Inc. | 4/9 | 1.61 | 61.2 | +59% |
| TDOC | Teladoc Health, Inc. | 5/9 | -16.73 | — | -1.5% |
About SBC Medical Group Holdings Inc
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
FAQ
Is SBC financially healthy?
SBC Medical Group Holdings Inc's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does SBC pay a dividend?
No, SBC Medical Group Holdings Inc does not currently pay a dividend.
How profitable is SBC?
In FY2025, SBC Medical Group Holdings Inc had a net margin of 29.4% and a return on equity of 19.4%.
What is SBC's P/E ratio?
SBC Medical Group Holdings Inc's trailing price-to-earnings (P/E) ratio is about 6.7×, based on its latest annual earnings.
What is the analyst price target for SBC?
The average Wall-Street price target for SBC Medical Group Holdings Inc is $8.50, about 165.6% above the recent price, from 4 analysts.
Is SBC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on SBC Medical Group Holdings Inc: a Piotroski F-score of 3/9, an Altman Z″ in the safe zone, a P/E of about 6.7×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.